Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity | NEJM - nejm.org

Correspondence from The New England Journal of Medicine — Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

Joseph Domachowske, M.D.State University of New York Upstate Medical University, Syracuse, NY Shabir A. Madhi, Ph.D.University of the Witwatersrand, Johannesburg, South Africa Eric A.F. Simões, M.D… [+765 chars]

full article...